Skip to main content

Month: May 2020

Gladstone Land Completes Acquisition of Irrigated Farmland in Nebraska

MCLEAN, Va., May 07, 2020 (GLOBE NEWSWIRE) — Gladstone Land Corporation (Nasdaq: LAND) (“Gladstone Land” or the “Company”) announced that it has acquired 678 gross acres of farmland in Chase County, Nebraska, for $3.5 million. The farm consists of 648 irrigated acres and will grow a rotation of potatoes, edible beans, and corn. In connection with the acquisition, Gladstone Land also entered into a seven-year, triple-net lease with a local, well-respected tenant who will process all the potatoes raised on the farm at one of their own facilities.“We continue to add farms in this area due to the good water, crop diversity, and the ability to find quality tenants” said Bill Hughes, Managing Director of Gladstone Land. “We are especially excited when we can find tenants that are willing to grow a quality, non-GMO product that consumers...

Continue reading

Denali Therapeutics Reports First Quarter 2020 Financial Results and Provides COVID-19 Response Update

SOUTH SAN FRANCISCO, May 07, 2020 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (“BBB”) for neurodegenerative diseases, today reported financial results for the first quarter ended March 31, 2020 and provided an update on the Company’s response to COVID-19.“Our commitment to defeat degeneration for our patients remains undeterred and we are working tirelessly toward our goals, with key data and decisions on track for mid-year 2020, despite the challenging external environment imposed by the pandemic,” said Ryan Watts, Ph.D., CEO. “We are also looking forward to DNL310 clinical biomarker data in Hunter syndrome in late 2020, with the goal of validating our Transport Vehicle platform...

Continue reading

Atrion Reports First Quarter Results

ALLEN, Texas, May 07, 2020 (GLOBE NEWSWIRE) — Atrion Corporation (Nasdaq – ATRI) today announced that revenues for the quarter ended March 31, 2020 were $43.6 million compared with $41.6 million for the same period in 2019. Net income in the current-year quarter totaled $8.9 million compared to $9.4 million in last year’s first quarter, with diluted earnings per share for the first quarter of 2020 at $4.79 compared to $5.07 for the first quarter of 2019.In announcing results for the first quarter of 2020, David A. Battat, President & CEO, said, “Before discussing our results, I wish to express my gratitude to my co-workers for their truly exceptional efforts during the COVID-19 pandemic. All of our facilities have remained operational thanks to their dedication. This was a monumental effort requiring the modification...

Continue reading

QIWI to Announce First Quarter 2020 Financial Results on May 20, 2020

NICOSIA, Cyprus, May 07, 2020 (GLOBE NEWSWIRE) — QIWI plc, (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”) today announced that it will host a conference call and webcast on Wednesday, May 20, 2020 at 8:30 a.m. ET to review first quarter 2020 financial results. A press release with first quarter 2020 financial results will be issued before the market opens on Wednesday, May 20, 2020.The conference call can be accessed live over the phone by dialing +1 (877) 407-3982 or for international callers by dialing +1 (201) 493-6780. A replay will be available at 11:30 a.m. ET and can be accessed by dialing +1 (844) 512-2921 or +1 (412) 317-6671 for international callers; the pin number is 13703572 The replay will be available until Wednesday, June 3, 2020. The call will be webcast live from the Company’s website at https://www.qiwi.com...

Continue reading

Spring Bank Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results

Continues to advance IV SB 11285 clinical trial to additional dosing cohortsOn track to include Roche’s Tecentriq® in IV SB 11285 clinical trial in summer 2020Advancing efforts to examine RIG-I and STING agonists portfolio as potential therapeutics and/or vaccine adjuvants for COVID-19HOPKINTON, Mass., May 07, 2020 (GLOBE NEWSWIRE) — Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of certain cancers and inflammatory diseases, today announced its financial results for the first quarter ended March 31, 2020 and provided an update on recent corporate and clinical development highlights.“Despite the negative impact of the COVID-19 pandemic on the conduct of clinical trials throughout our industry, we have been fortunate to find ways to continue...

Continue reading

StoneCastle Financial Corp. Reports First Quarter 2020 Results

DENVER, May 07, 2020 (GLOBE NEWSWIRE) — StoneCastle Financial Corp. (Nasdaq: BANX) (“StoneCastle Financial” or the “Company”), an investment company registered with the Securities and Exchange Commission (“SEC”), today announced results for the first fiscal quarter ended March 31, 2020.   First Quarter 2020 Investment Highlights:Realized full redemptions of $10.4 million from two investmentsRealized proceeds from a partial call of $1.5 million from one investmentRealized proceeds from paydowns of $1.5 million from two investmentsA complete listing of investments as of the end of the quarter can be found on the Company’s website at www.stonecastle-financial.com.First Quarter 2020 Financial ResultsNet investment income was $2,530,138 or $0.39 per share, comprised of $3,685,293 gross income and $1,155,155 of expenses.  For the quarter,...

Continue reading

Ooma Schedules First Quarter Fiscal 2021 Results

SUNNYVALE, Calif., May 07, 2020 (GLOBE NEWSWIRE) — Ooma, Inc. (NYSE: OOMA), a smart communications platform for businesses and consumers, announced that it plans to release its financial results for the first quarter ended April 30, 2020 after the market closes on Tuesday, May 26, 2020. The company will host a conference call and live webcast for analysts and investors at 5:00 p.m., Eastern time on that day. The news release with the financial results will be accessible from the company’s website prior to the conference call.Parties in the United States and Canada can access the call by dialing +1 (833) 513-0546, using conference ID 7219915 to complete the automated access process. International parties can access the call by dialing +1 (778) 560-2568, using conference ID 7219915.The webcast will be accessible on the Events...

Continue reading

HCI Group Reports First Quarter 2020 Results

TAMPA, Fla., May 07, 2020 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), an InsurTech company with operations in insurance, software development and real estate, reported results for the quarter ended March 31, 2020.First Quarter 2020 – Financial ResultsNet income for the first quarter of 2020 totaled $0.5 million or $0.07 diluted earnings per share compared with $6.7 million or $0.82 diluted earnings per share in the first quarter of 2019. Adjusted net income (a non-GAAP measure which excludes net unrealized gains or losses on equity securities) for the quarter was $4.2 million or $0.54 diluted earnings per share compared with $2.8 million or $0.35 diluted earnings per share in the first quarter of 2019. The company has included in this press release an explanation of adjusted net income as well as a reconciliation to net...

Continue reading

OceanFirst Financial Corp. Announces Virtual Only Meeting Format For 2020 Annual Meeting Of Stockholders

RED BANK, N.J., May 07, 2020 (GLOBE NEWSWIRE) — OceanFirst Financial Corp. (NASDAQ:OCFC, the “Company”), the holding company for OceanFirst Bank N.A., today announced that the 2020 Annual Meeting of Stockholders scheduled for May 20, 2020 at 9:00 a.m. Eastern Time will be held in a virtual meeting format only.  Due to public health and safety concerns related to the COVID-19 pandemic, and in order to comply with federal and state health guidance and executive orders, shareholders and guests will not be permitted to attend the meeting in person.OceanFirst Financial Corp. eligible stockholders of record as of the close of business on April 3, 2020 are invited to participate in the live audio webcast of the virtual meeting which will offer the same rights and opportunities to participate in the virtual Annual Meeting as at an in-person...

Continue reading

Globus Medical Reports First Quarter 2020 Results

AUDUBON, Pa., May 07, 2020 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2020.Worldwide sales were $190.6 million, an increase of 4.2% as reportedFirst quarter net income was $25.9 millionDiluted earnings per share (EPS) was $0.25 and non-GAAP diluted EPS was $0.29Non-GAAP adjusted EBITDA was 26.5% of sales“The COVID-19 pandemic presents one of the greatest healthcare challenges we have faced in recent history. We remain diligent in our commitment to protect the health of our people, support our surgeons and patients in need, and keep our company strong,” said Dave Demski, President and CEO. As we chart a course through this extraordinary and challenging time together, we have been heartened at every turn...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.